Clinical data | |
---|---|
Other names | Chlordione; 17α-Hydroxy-6-chloro-6-dehydroprogesterone; 17α-Hydroxy-6-chloropregna-4,6-diene-3,20-dione; 6-Chloro-17α-hydroxypregna-4,6-diene-3,20-dione |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.185 |
Chemical and physical data | |
Formula | C21H27ClO3 |
Molar mass | 362.89 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Chlormadinone is a progestin which was never marketed. An acylated derivative, chlormadinone acetate, is used clinically as a pharmaceutical drug.
It was patented in 1958 and approved for medical use in 1963. While chlormadinone is sometimes used as a synonym for chlormadinone acetate, what is almost always being referred to is chlormadinone acetate and not chlormadinone.
See also
References
- ^ Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 419. ISBN 978-0-412-46630-4. Retrieved 29 May 2012.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 215. ISBN 978-3-88763-075-1. Retrieved 29 May 2012.
- Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 478. ISBN 9783527607495.
This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |
This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |